Objectives: Stereotactic body radiotherapy (SBRT) is potentially curative treatment for small
hepatocellular carcinomas (HCC), but data are limited on its efficacy and toxicity. We …

Stereotactic Body Radiation Therapy (SBRT) is an emerging effective treatment for
hepatocellular carcinoma (HCC) associated with acceptable rates of toxicity in appropriately …

Purpose To describe outcomes of prospective trials of stereotactic body radiotherapy (SBRT)
for hepatocellular carcinoma (HCC). Patients and Methods Two trials of SBRT for patients …

Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local
control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been …

Hepatocellular carcinoma (HCC) is the most common malignancy in the world and the most
common cause of cancer-related death. Surgical resection is the standard of care for solitary …

Purpose To examine safety and efficacy of stereotactic body radiation therapy (SBRT) for
centrally located hepatocellular carcinoma (CL-HCC). Methods Fifty-three patients with CL …

Overview: Stereotactic body radiotherapy (SBRT), in which highly conformal potent radiation
doses are delivered in fewer fractions than traditional radiation therapy (RT), is an …

The integration of new technologies has raised an interest in liver tumor radiotherapy, with
literature evolving to support its efficacy. These advances, particularly stereotactic body …

Purpose To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the
treatment of inoperable hepatocellular carcinoma. Methods The records of 77 consecutive …

Aims Stereotactic body radiotherapy (SBRT) is an option for the treatment of hepatocellular
carcinoma (HCC) in patients ineligible for standard local therapies. This study reports on the …